Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). - Abstract - Europe PMC
Fulvestrant - an overview | ScienceDirect Topics
T3DB: Fulvestrant
Clinical Trial Protocol Template
Differential Pulse Voltammetric Determination of Fulvestrant in Pharmaceutical Dosage Forms and Serum Samples
PDF) Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)
fulvestrant | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Estrogen receptor - Wikipedia
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). - Abstract - Europe PMC
Fulvestrant - wikidoc
ASCO Highlight: Another Treatment Option for ER-Positive Breast Cancer - Cancer Commons
PharmaWiki - Fulvestrant
Fulvestrant in advanced breast cancer: evidence to date and place in therapy - Katalin Boér, 2017
Fulvestrant - wikidoc
METAP2 - Wikipedia
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD). - Abstract - Europe PMC
Fulvestrant | C32H47F5O3S | CID 104741 - PubChem
Oncology
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients | Fierce Biotech
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). - Abstract - Europe PMC
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)
